Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma.
DNA methyltransferase 3A (DNMT3A) is an enzyme involved in DNA methylation that is frequently mutated in human hematologic malignancies. We have previously shown that inactivation of Dnmt3a in hematopoietic cells results in chronic lymphocytic leukemia in mice. Here we show that 12% of Dnmt3a-deficient mice develop CD8+ mature peripheral T cell lymphomas (PTCL) and 29% of mice are affected by both diseases. 10% of Dnmt3a+/- mice develop lymphomas, suggesting that Dnmt3a is a haploinsufficient tumor suppressor in PTCL. DNA methylation was deregulated genome-wide with 10-fold more hypo- than hypermethylated promoters and enhancers, demonstrating that hypomethylation is a major event in the development of PTCL. Hypomethylated promoters were enriched for binding sites of transcription factors AML1, NF-κB and OCT1, implying the transcription factors potential involvement in Dnmt3a-associated methylation. Whereas 71 hypomethylated genes showed an increased expression in PTCL, only 3 hypermethylated genes were silenced, suggesting that cancer-specific hypomethylation has broader effects on the transcriptome of cancer cells than hypermethylation. Interestingly, transcriptomes of Dnmt3a+/- and Dnmt3aΔ/Δ lymphomas were largely conserved and significantly overlapped with those of human tumors. Importantly, we observed downregulation of tumor suppressor p53 in Dnmt3a+/- and Dnmt3aΔ/Δ lymphomas as well as in pre-tumor thymocytes from 9 months old but not 6 weeks old Dnmt3a+/- tumor-free mice, suggesting that p53 downregulation is chronologically an intermediate event in tumorigenesis. Decrease in p53 is likely an important event in tumorigenesis because its overexpression inhibited proliferation in mouse PTCL cell lines, suggesting that low levels of p53 are important for tumor maintenance. Altogether, our data link the haploinsufficient tumor suppressor function of Dnmt3a in the prevention of mouse mature CD8+ PTCL indirectly to a bona fide tumor suppressor of T cell malignancies p53.
Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Staci L
SL
Haney
Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
G Michael
http://orcid.org/0000-0003-4193-0733
GM
Upchurch
Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Jana
J
Opavska
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
David
D
Klinkebiel
Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America.
Ryan A
http://orcid.org/0000-0002-2829-4237
RA
Hlady
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Sohini
S
Roy
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Samikshan
S
Dutta
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Kaustubh
K
Datta
Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.|Eppley Institute for Research in Cancer and Allied Diseases, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.|Center for Leukemia and Lymphoma Research, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
Rene
R
Opavsky
N Engl J Med. 2010 Dec 16;363(25):2424-33
21067377
Nat Genet. 2015 Dec;47(12):1426-34
26551670
Leukemia. 2014 Sep;28(9):1828-37
24625531
PLoS One. 2009 Sep 17;4(9):e7089
19759907
Mol Cell Biol. 2001 May;21(9):3012-24
11287607
Nucleic Acids Res. 2015 Dec 2;43(21):e141
26184873
Blood. 2015 Jan 22;125(4):629-38
25416277
Leukemia. 2014 May;28(5):1138-42
24292811
Mol Cancer. 2010 Mar 09;9:54
20214788
Genome Biol. 2013 Apr 25;14(4):R36
23618408
Cell. 1999 Oct 29;99(3):247-57
10555141
Mol Cancer. 2014 Jul 18;13:175
25037230
Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4742-7
10758156
Genome Res. 2009 Sep;19(9):1639-45
19541911
Bioinformatics. 2011 Jun 1;27(11):1571-2
21493656
Leukemia. 2005 May;19(5):847-50
15744335
Int J Hematol. 2016 Feb;103(2):196-201
26676804
Brief Funct Genomics. 2010 Dec;9(5-6):455-65
21266347
Nat Biotechnol. 2013 Jan;31(1):46-53
23222703
Cancer Res. 1997 Mar 1;57(5):837-41
9041182
Oncogene. 2013 Jan 17;32(3):397-402
22370638
J Exp Med. 2008 Dec 22;205(13):2965-73
19029380
J Clin Invest. 2012 Jan;122(1):163-77
22133874
J Biol Chem. 1999 Nov 12;274(46):33002-10
10551868
Blood. 2002 Apr 1;99(7):2291-6
11895758
Leukemia. 2016 May;30(5):1133-42
26710888
Nat Genet. 2011 Dec 04;44(1):23-31
22138693
Science. 2014 Aug 22;345(6199):943-9
25103404
BMC Bioinformatics. 2011 Dec 30;12:495
22208852
Nat Rev Cancer. 2015 Mar;15(3):152-65
25693834
Cancer Res. 2005 Nov 1;65(21):9971-81
16267022
Cell Rep. 2016 May 10;15(6):1190-201
27134162
Nat Genet. 2014 Jan;46(1):17-23
24270360
Bioinformatics. 2010 Mar 15;26(6):841-2
20110278
Mol Carcinog. 1995 Sep;14(1):16-22
7546219
Blood. 2015 Oct 8;126(15):1741-52
26268241
J Virol. 2003 Jul;77(14):7728-35
12829812
Oncotarget. 2016 Mar 1;7(9):9939-50
26799420
Epigenetics. 2009 Oct 1;4(7):487-99
19786833
Nat Genet. 2009 Nov;41(11):1207-15
19801979
Nat Genet. 2003 Jan;33(1):61-5
12496760
Cell Stem Cell. 2014 Sep 4;15(3):350-64
25130491
Leukemia. 2014 Aug;28(8):1687-97
24480986
Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11293-8
12151601
Nat Immunol. 2010 Aug;11(8):717-24
20622884
J Virol. 2005 Dec;79(23):14536-45
16282453
Blood. 2015 Jan 22;125(4):619-28
25416276
Mol Cancer. 2015 Feb 03;14:26
25644173
Cancer Cell. 2006 Jul;10(1):77-87
16843267
Mol Cell Biol. 2013 Nov;33(21):4321-33
24001767
Nat Methods. 2014 Nov;11(11):1138-40
25262207
Bioinformatics. 2012 Aug 15;28(16):2180-1
22689387
Oncogene. 2015 Oct;34(43):5436-46
25639876
Bioinformatics. 2009 Jan 15;25(2):167-74
19017655
Blood. 2011 Aug 18;118(7):e32-9
21685375